SCS
CMPX icon

Sound Capital Solutions’s Compass Therapeutics CMPX Stock Holding History

Sound Capital Solutions’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$176K Buy
+80,160
New +$237K 0.04% 305

Other funds holding CMPX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Sound Capital Solutions's CMPX Position: Q2 2026 in Review

Sound Capital Solutions opened a new position in Compass Therapeutics (CMPX) in Q2 2026: 80,160 shares worth $176K. The stake represents 0.04% of the portfolio and ranks #305 among its holdings.

197 funds tracked by Wall St. Rank hold CMPX as of Q2 2026.

  • Sound Capital Solutions held 80,160 shares of Compass Therapeutics worth $176K as of Q2 2026.
  • Compass Therapeutics was a new Sound Capital Solutions position in Q2 2026.
  • Compass Therapeutics made up 0.04% of Sound Capital Solutions's portfolio in Q2 2026, its #305 holding.
  • 197 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2026.

Based on Sound Capital Solutions's 13F filing for Q2 2026, filed 13 Aug 2026.